Life science specialist fund Decheng Capital eyes $700m for Fund V

Life science specialist fund Decheng Capital eyes $700m for Fund V

06 October, 2025

Edited by: Joymitra Rai

biotech Decheng Capital Decheng Capital Global Life Sciences Fund V Epimab Biotherapeutics healthcare Impact Therapeutics life sciences

Printed by Unregistered user on Mon, 06 Oct 2025 12:09:48 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

China's Sunho Biotech acquires SG-based waste management firm

Lack of venture builders may delay growth of longevity biotech in Asia

Read more from Greater China

Bubble-tea maker Mixue moves into beer market

Earnings and Results

Foxconn Q3 revenue hits record led by strong demand for AI products